Epipen Auto-Injector And Junior Auto-Injector 0,3 mg. Solution for injection in pre-filled pen
PDF Leaflet Revision Date: 07 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Emergency treatment of severe anaphylactic reactions.
Dosage (summary)
EPIPEN 0.3 mg for patients u226530 kg; EPIPEN JUNIOR 0.15 mg for patients 15-30 kg.
Special Populations
- Elderly
- Pregnant women
- Children under 25 kg
Pregnancy & Breastfeeding
First-line treatment for anaphylaxis; use as in non-pregnant patients.
Key Drug Interactions
- Cardiac glycosides
- Beta-blockers
- Tricyclic antidepressants
Common side effects
- Palpitations
- Tachycardia
- Hypertension
- Nausea
- Vomiting
Counselling Points
- Seek immediate medical help after use
- Educate caregivers on administration
- Inspect solution for discoloration
Serious warnings
- Injection-related complications
- Risk of serious infections
- Cerebral hemorrhage from overdose
Important Disclaimer
The Epipen Auto-Injector And Junior Auto-Injector 0,3 mg. Solution for injection in pre-filled pen professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
